—
Grey Stone Laboratories located in Irving, Texas, announces its updated list of genomic testing and toxicology screening services. The state-of-the-art laboratory helps residents detect their genetic vulnerability to various illnesses, including cancer, cardiovascular disease, and diabetes, among others.
More details can be found at https://www.greystonelaboratories.com/about
The updated testing services address the need in the market for accessible, affordable, and accurate lab results for genetic vulnerabilities. By determining one’s predisposition to a chronic disease, necessary lifestyle changes can be made to prevent it. The results are also useful for individuals planning to be parents, as they will know what conditions they could be potentially passing on to their children.
Genomic testing has improved in the last few decades, with scientists now being able to determine the specific chromosomes that predispose a person to a specific disease. Breast, lung, ovarian, and prostate cancers, in particular, are conditions that are more probable to manifest if one is genetically predisposed to them.
Grey Stone Labs is dedicated to helping residents learn more about themselves. It is built on three missions: identity, protect, and partner.
The lab works closely with physicians to create customized testing options to meet the needs of both the patient and doctor. Likewise, it understands that genomic testing is constantly evolving and has partnered with a referring physician network to constantly bring other solutions that can improve its services.
Grey Stone Laboratories is also compliant with the latest health and safety guidelines and continuously has its facilities tested to ensure that all of its equipment is in good working condition. This allows them to test and produce comprehensive genomic results in less than 24 hours.
Apart from genomic testing, the lab also offers a wide selection of toxicology testing, screening, and confirmation panels.
The lab constantly keeps itself updated on the latest research on genomic screening and announces that it may have other tests in the future. To date, the lab can test for breast, lung, ovarian, and prostate cancer, cardiovascular disease, obesity, Alzheimer’s, and diabetes.
Patients are encouraged to schedule an appointment online.
Release ID: 89038269